Covista (CVSA) Asset Writedowns and Impairment (2010 - 2026)

Covista (CVSA) has 15 years of Asset Writedowns and Impairment data on file, last reported at $16.8 million in Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $16.8 million, down 6.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.5 million (down 31.41% YoY), and the FY2025 annual result was $61.3 million, up 22.02% from the prior year.
• Asset Writedowns and Impairment climbed to $16.8 million in Q1 2026 per CVSA's latest filing, from $16.3 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $49.6 million in Q2 2024 and troughed at $600000.0 in Q4 2023.
• A 4-year average of $17.6 million and a median of $15.5 million in 2024 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment surged 2335.5% in 2024, then tumbled 65.99% in 2025.
• A 4-year view of Asset Writedowns and Impairment shows it stood at $600000.0 in 2023, then surged by 2335.5% to $14.6 million in 2024, then climbed by 11.78% to $16.3 million in 2025, then advanced by 2.94% to $16.8 million in 2026.
• Business Quant data shows CVSA's Asset Writedowns and Impairment at $16.8 million in Q1 2026, $16.3 million in Q4 2025, and $14.5 million in Q3 2025.